Reverse Stock Split at Medical Test Firm
Disease Detection International Inc., an Irvine manufacturer of medical diagnostic test kits for hospitals and doctors offices, said Monday that its shareholders have approved a reverse stock plan.
The action will reduce the publicly traded shares in the company while increasing the amount of new stock the company may sell in the future.
The plan, aimed at meeting price requirements to keep the stock listed on the National Association of Security Dealers listings, will reduce the number of common shares outstanding from 188,707,484 to approximately 4,717,484188.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
